pharmaphorum

MARCH 19, 2021

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. on Big data: astronomical or genomical? ,

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

pharmaphorum

JULY 5, 2022

I recently had the pleasure of attending the PING Conference 2022 , which had the tagline of ‘The Golden Age for Life Sciences Innovation’. Aspirations for the UK in life sciences. So, with all that said, are we really in a golden age for UK life sciences? Reducing complexity across the NHS.

Life Science 98

Life Science Medicine Biobanking Research 98

XTalks

APRIL 15, 2021

New advances in heart failure genomics are helping to address this challenge. Experts from Servier and Genuity Science recently spoke on a webinar about using genomics data to drive drug development in heart failure and identify new targets for novel therapeutics. Watch this on-demand webinar to hear from these experts.

Development 88

Development Drugs Genomics Genome 88

XTalks

SEPTEMBER 16, 2022

They performed ultra-deep genomic profiling of normal lung tissue samples and tissues exposed to PM (both human and mouse tissues) and examined the effects of the PM on tumor promotion in mouse lung cancer models. The researchers performed a combination of human and animal experiments to examine a potential link between PM 2.5

Research 77

Research Gene Scientist Biobanking 77

XTalks

FEBRUARY 4, 2021

The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Biobanks are used for the coordination of high-yield patient sample collection. Generation of strong research dataset cohorts must begin with high-quality clinical samples.

Research 96

Research Biobanking Drugs Genome 96

The Pharma Data

APRIL 11, 2023

About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. The company’s approach to research prioritizes targets and pathways with the potential to impact the way that cancer is treated.

Research 40

Research Clinical Trials Clinical Trials Trials 40